Volume 17 Issue 2
Jun.  2004
Turn off MathJax
Article Contents

DE-YU LIU, JIAN-TAO YE, WEN-HUI YANG, JIN YAN, CHANG-HONG ZENG, SA ZENG. Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry[J]. Biomedical and Environmental Sciences, 2004, 17(2): 153-164.
Citation: DE-YU LIU, JIAN-TAO YE, WEN-HUI YANG, JIN YAN, CHANG-HONG ZENG, SA ZENG. Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry[J]. Biomedical and Environmental Sciences, 2004, 17(2): 153-164.

Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry

Funds:  广东省自然科学基金(97002)
  • Objective To investigate the anti-HIV effects of ampelopsin and its interaction with HIV-1 coreceptor CXCR4. Methods Through anti-virus experiments in vitro, the inhibitory effect of ampelopsin on HIV-1 infection was verified. Chemotaxis assay was performed to show the ability to induce PBMCs migration by ampelopsin, RANTES and SDF-1(. Fluorescence labelling monoclonal antibody was utilized to observe the interaction of ampelopsin and CXCR4. Mice immunosuppressant model was also established to detail the role ampelopsin played in regulating cellular immunological functions. Results Ampelopsin could protect sensitive cells against HIV-1 infection and dramatically reduce HIV-1 antigen P24 expression. HIV-1SF33 attaching to MT-4 cells was interfered by ampelopsin, and the EC50 was 0.175 mg/mL for cellular protection and 0.024 mg/mL for P24 inhibition. At co-cultivating phase, EC50 was 0.229 mg/mL and 0.197 mg/mL respectively. Furthermore, the EC50 was 0.179 mg/mL and 0.348 mg/mL in acute infection. Human PBMCs migration was induced after being challenged with ampelopsin or chemokines, and synergistic action was observed during co-treatment. Ampelopsin alone resulted in maximal chemotaxis at 1 mg/mL. HIV-1 co-receptor CXCR4 on the surface of PBMCs was decreased by internalization, which indicated the effect of ampelopsin on CXCR4. About 70% CXCR4 was reduced by ampelopsin at 1 mg/mL. Ampelopsin also augmented cellular immunological functions in immunosuppressive mice. Conclusion Ampelopsin displays a strong inhibitive role during HIV-1 absorption, incubation and acute infection. These results are coincident with its immune enhancement.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1049) PDF downloads(25) Cited by()

Proportional views
Related

Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry

Funds:  广东省自然科学基金(97002)

Abstract: Objective To investigate the anti-HIV effects of ampelopsin and its interaction with HIV-1 coreceptor CXCR4. Methods Through anti-virus experiments in vitro, the inhibitory effect of ampelopsin on HIV-1 infection was verified. Chemotaxis assay was performed to show the ability to induce PBMCs migration by ampelopsin, RANTES and SDF-1(. Fluorescence labelling monoclonal antibody was utilized to observe the interaction of ampelopsin and CXCR4. Mice immunosuppressant model was also established to detail the role ampelopsin played in regulating cellular immunological functions. Results Ampelopsin could protect sensitive cells against HIV-1 infection and dramatically reduce HIV-1 antigen P24 expression. HIV-1SF33 attaching to MT-4 cells was interfered by ampelopsin, and the EC50 was 0.175 mg/mL for cellular protection and 0.024 mg/mL for P24 inhibition. At co-cultivating phase, EC50 was 0.229 mg/mL and 0.197 mg/mL respectively. Furthermore, the EC50 was 0.179 mg/mL and 0.348 mg/mL in acute infection. Human PBMCs migration was induced after being challenged with ampelopsin or chemokines, and synergistic action was observed during co-treatment. Ampelopsin alone resulted in maximal chemotaxis at 1 mg/mL. HIV-1 co-receptor CXCR4 on the surface of PBMCs was decreased by internalization, which indicated the effect of ampelopsin on CXCR4. About 70% CXCR4 was reduced by ampelopsin at 1 mg/mL. Ampelopsin also augmented cellular immunological functions in immunosuppressive mice. Conclusion Ampelopsin displays a strong inhibitive role during HIV-1 absorption, incubation and acute infection. These results are coincident with its immune enhancement.

DE-YU LIU, JIAN-TAO YE, WEN-HUI YANG, JIN YAN, CHANG-HONG ZENG, SA ZENG. Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry[J]. Biomedical and Environmental Sciences, 2004, 17(2): 153-164.
Citation: DE-YU LIU, JIAN-TAO YE, WEN-HUI YANG, JIN YAN, CHANG-HONG ZENG, SA ZENG. Ampelopsin, a Small Molecule Inhibitor of HIV-1 Infection Targeting HIV Entry[J]. Biomedical and Environmental Sciences, 2004, 17(2): 153-164.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return